Abstract
Gangliosides make up a group of sialic acid-containing complex glycosphingolipids particularly abundant in the central nervous system. The finding indicating gangliosides are stored in certain hereditary diseases affecting the central nervous system opened the interest in studying their metabolism. The initial in vitro pioneering work on the glycosyltransferases involved in ganglioside biosynthesis was done by Roseman and his associates primarily in embryonic chick brains almost forty years ago. Since that time enzymes catalyzing the formation of main human gangliosides have been successfully purified and cloned. Their specificity has been determined and their subcellular localization and topology has been established. Transgenic mouse models deficient in distinct ganglioside-directed glycosyltransferases are available and represent a vital step toward understanding the metabolism and function of this challenging lipid class. In the present review we briefly introduce the reader in the complex structure of gangliosides, then we summarize new developments concerning their function especially regarding neurodegenerative disorders, and in this article we would like to review on what is known about glycosyltransferases that catalyze the formation of these complex lipids in the Golgi apparatus, that was established by Basu and his associates almost three decades ago.
Current Drug Targets
Title: Golgi Localization of Glycosyltransferases Involved in Ganglioside Biosynthesis
Volume: 9 Issue: 4
Author(s): Gerhild van Echten-Deckert and Mihaela Guravi
Affiliation:
Abstract: Gangliosides make up a group of sialic acid-containing complex glycosphingolipids particularly abundant in the central nervous system. The finding indicating gangliosides are stored in certain hereditary diseases affecting the central nervous system opened the interest in studying their metabolism. The initial in vitro pioneering work on the glycosyltransferases involved in ganglioside biosynthesis was done by Roseman and his associates primarily in embryonic chick brains almost forty years ago. Since that time enzymes catalyzing the formation of main human gangliosides have been successfully purified and cloned. Their specificity has been determined and their subcellular localization and topology has been established. Transgenic mouse models deficient in distinct ganglioside-directed glycosyltransferases are available and represent a vital step toward understanding the metabolism and function of this challenging lipid class. In the present review we briefly introduce the reader in the complex structure of gangliosides, then we summarize new developments concerning their function especially regarding neurodegenerative disorders, and in this article we would like to review on what is known about glycosyltransferases that catalyze the formation of these complex lipids in the Golgi apparatus, that was established by Basu and his associates almost three decades ago.
Export Options
About this article
Cite this article as:
Echten-Deckert van Gerhild and Guravi Mihaela, Golgi Localization of Glycosyltransferases Involved in Ganglioside Biosynthesis, Current Drug Targets 2008; 9 (4) . https://dx.doi.org/10.2174/138945008783954989
DOI https://dx.doi.org/10.2174/138945008783954989 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cultured Adult Animal Neurons and Schwann Cells Give Us New Insights into Diabetic Neuropathy
Current Diabetes Reviews Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations
Current Alzheimer Research RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules
Current Pharmaceutical Design Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition
Current Medicinal Chemistry - Central Nervous System Agents Molecular Profiling - An Essential Technology Enabling Personalized Medicine in Breast Cancer
Current Drug Targets Disease-Specific iPS Cell Models in Neuroscience
Current Molecular Medicine Bacterial Protein Toxins: Current and Potential Clinical Use
Current Medicinal Chemistry Crystal Structure of a Cu,Zn Superoxide Dismutase From the Thermophilic Fungus <i>Chaetomium thermophilum</i>
Protein & Peptide Letters AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved
Current Signal Transduction Therapy Joshanda: A Traditional Herbal Approach for Treatment of Respiratory Catarrh
Current Respiratory Medicine Reviews Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry 9th International Meeting on Metabotropic Gglutamate Receptors (Taormina, Sicily, October 1-6, 2017).
Current Neuropharmacology Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Recent Patents in Dendrimers for Nanomedicine: Evolution 2014
Recent Patents on Nanomedicine The Potential of Serratiopetidase and Lumbrokinase for the Degradation of Prion Peptide 106-126 - an <i>In Vitro</i> and <i>In Silico</i> Perspective
CNS & Neurological Disorders - Drug Targets